Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125807722 | 12580772 | 2 | F | 20160726 | 20160721 | 20160802 | EXP | JP-DSJP-DSJ-2016-124450 | DAIICHI | 0.00 | Y | 0.00000 | 20160802 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125807722 | 12580772 | 1 | PS | LIXIANA TABLETS | EDOXABAN TOSILATE MONOHYDRATE | 1 | Unknown | 30MG/DAY | Y | 206316 | TABLET | ||||||||
| 125807722 | 12580772 | 2 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125807722 | 12580772 | 3 | C | MAGMITT | MAGNESIUM OXIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125807722 | 12580772 | 1 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125807722 | 12580772 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125807722 | 12580772 | Activated partial thromboplastin time prolonged | |
| 125807722 | 12580772 | Bradycardia | |
| 125807722 | 12580772 | Hyperkalaemia | |
| 125807722 | 12580772 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |